ATP Synthesis-IN-3
ATP Synthesis-IN-3 (compound 31) is an inhibitor of ATP hydrolysis that provides a protective effect during myocardial ischemia. It increases ATP levels in ischemic myocardial cells, enhances the phosphorylation of PKA and substrate proteins, and inhibits ischemia-induced apoptosis (cell apoptosis) .
Product Specifications
CAS Number
3032416-36-4
Field of Research
Pharmacology & Drug Discovery, Signal Transduction
Smiles
N=1C (=CC=2C (=NN (C2C1N3CCOCC3) CC4=CC=C (OC) C=C4) C=5C=CC=CC5) NC6=CC=C (C=C6) N7CCN (C) CC7
Molecular Formula
C35H39N7O2
Molecular Weight
589.73
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1394253-01 0.02 mg (E-Coli)
Recombinant Rat V-type proton ATPase subunit C 1 (Atp6v1c1)
Sign In for Pricing
View Details MBS1394253-02 0.02 mg (Yeast)
Recombinant Rat V-type proton ATPase subunit C 1 (Atp6v1c1)
Sign In for Pricing
View Details MBS1394253-03 0.1 mg (E-Coli)
Recombinant Rat V-type proton ATPase subunit C 1 (Atp6v1c1)
Sign In for Pricing
View Details MBS1394253-04 0.1 mg (Yeast)
Recombinant Rat V-type proton ATPase subunit C 1 (Atp6v1c1)
Sign In for Pricing
View Details MBS1394253-05 0.02 mg (Baculovirus)
Recombinant Rat V-type proton ATPase subunit C 1 (Atp6v1c1)
Sign In for Pricing
View Details MBS1394253-06 0.02 mg (Mammalian-Cell)
Recombinant Rat V-type proton ATPase subunit C 1 (Atp6v1c1)
Sign In for Pricing
View Details